{"id":185277,"name":"TEVA PHARMACEUTICALS USA, INC.","slug":"teva-pharmaceuticals-usa-inc","state":"PA","description":"pharmaceutical company","totalSpending":1195000,"filings":15,"yearlySpending":[{"year":2019,"income":235000},{"year":2020,"income":320000},{"year":2021,"income":320000},{"year":2022,"income":320000}],"firms":["POLSINELLI PC"],"lobbyists":["JAMES DAVIDSON","SYLVIA KORNEGAY","JULIUS HOBSON","HARRY SPORIDIS","STEVEN STRANNE","ALAN WHEAT","TIM PERRIN","ROBERT DALEY","SHELAGH FOSTER"],"issues":["HCR","PHA","MMM","MED"],"sampleDescriptions":["Issues pertaining to pharmaceutical and healthcare markets","H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act\nH.R.965/ S.340, CREATES Act\nH.R.1503, Orange Book Transparency Act\nH.R.1520, Purple Book Continuity Act\nH.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act\nH.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act\nH.R.2376/ S.1227, Prescription Pricing for the People Act\nS.1416, Affordable Prescriptions for Patients Act\nS.1895, Lower Health Care Costs Act\nH.R. 1499, Protecting Consumer Access to Generic Drugs Act\nAdministration review of drug pricing policies","S.2543, Prescription Drug Pricing Reduction Act\nS.1895, Lower Health Care Costs Act\nH.R. 3, Lower Drug Costs Now Act\nH.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act\nH.R.2296, METRIC Act\nAdministration review of drug pricing policies","S.2543, Prescription Drug Pricing Reduction Act\nS.1895, Lower Health Care Costs Act\nH.R. 3, Lower Drug Costs Now Act\nH.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act\nH.R.1865, FY2020 Further Consolidated Appropriations Act\nAdministration review of drug pricing policies","S. 2543, Prescription Drug Pricing Reduction Act\nS. 1895, Lower Health Care Costs Act\nH.R. 3, Lower Drug Costs Now Act\nH.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act \nH.R. 6201, Families First Coronavirus Response Act\nH.R. 748, CARES Act\nReview of Administration drug pricing policies","S. 2543, Prescription Drug Pricing Reduction Act\nS. 1895, Lower Health Care Costs Act\nH.R. 3, Lower Drug Costs Now Act\nCoronavirus stimulus legislation \nReview of Administration drug pricing policies","S. 2543, Prescription Drug Pricing Reduction Act\nS. 1895, Lower Health Care Costs Act\nH.R. 3, Lower Drug Costs Now Act\nCoronavirus stimulus legislation \nReview of Administration drug pricing and telehealth policies\nH.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act","S. 2543, Prescription Drug Pricing Reduction Act\nS. 1895, Lower Health Care Costs Act\nH.R. 3, Lower Drug Costs Now Act\nH.R. 133, FY2021 Omnibus and COVID Relief and Response Act\nReview of Administration drug pricing and telehealth policies","H.R.1319, American Rescue Plan Act\nIssues related to pricing, reimbursement, and manufacturing of pharmaceutical products\nReview of Administration telehealth policies","Issues related to pricing, reimbursement, and manufacturing of pharmaceutical products\nReview of Administration telehealth policies","Issues related to pricing, reimbursement, and manufacturing of pharmaceutical products Review of Administration telehealth policies"],"years":[2019,2020,2021,2022]}